Scientific Literature Search

Source record

Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.

Galtier I, Nieto A, Lorenzo JN, Barroso J.

J Clin Exp Neuropsychol · 2015-11-25

DOI: 10.1080/13803395.2015.1087465PMID: 26602176

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage.

Franke SK, van Kesteren RE, Wubben JA, Hofman S, Paliukhovich I, van der Schors RC, van Nierop P, Smit AB, Philippens IH.

Neuroscience · 2015-10-09

DOI: 10.1016/j.neuroscience.2015.09.065PMID: 26431624

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?

Spittau B.

Neural Regen Res · 2015-10-01

DOI: 10.4103/1673-5374.165228PMID: 26692847

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.

Davis AA, Andruska KM, Benitez BA, Racette BA, Perlmutter JS, Cruchaga C.

Neurobiol Aging · 2015-09-30

DOI: 10.1016/j.neurobiolaging.2015.09.014PMID: 26601739

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Editorial: Parkinson's disease: cell vulnerability and disease progression.

Blesa J, Lanciego JL, Obeso JA.

Front Neuroanat · 2015-09-15

DOI: 10.3389/fnana.2015.00125PMID: 26441555

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease.

Terrelonge M, Marder KS, Weintraub D, Alcalay RN.

J Mol Neurosci · 2015-09-02

DOI: 10.1007/s12031-015-0647-xPMID: 26330275

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine.

Simon DK, Wu C, Tilley BC, Wills AM, Aminoff MJ, Bainbridge J, Hauser RA, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wong PS.

Clin Neuropharmacol · 2015-09-01

DOI: 10.1097/wnf.0000000000000102PMID: 26366971

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Greater motor progression in patients with Parkinson disease who carry LRRK2 risk variants.

Oosterveld LP, Allen JC, Ng EY, Seah SH, Tay KY, Au WL, Tan EK, Tan LC.

Neurology · 2015-08-26

DOI: 10.1212/wnl.0000000000001953PMID: 26311745

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI).

Nalls MA, Keller MF, Hernandez DG, Chen L, Stone DJ, Singleton AB, Parkinson's Progression Marker Initiative (PPMI) investigators.

Mov Disord · 2015-08-13

DOI: 10.1002/mds.26374PMID: 26268663

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.

Nalls MA, McLean CY, Rick J, Eberly S, Hutten SJ, Gwinn K, Sutherland M, Martinez M, Heutink P, Williams NM, Hardy J, Gasser T, Brice A, Price TR, Nicolas A, Keller MF, Molony C, Gibbs JR, Chen-Plotkin A, Suh E, Letson C, Fiandaca MS, Mapstone M, Federoff HJ, Noyce AJ, Morris H, Van Deerlin VM, Weintraub D, Zabetian C, Hernandez DG, Lesage S, Mullins M, Conley ED, Northover CA, Frasier M, Marek K, Day-Williams AG, Stone DJ, Ioannidis JP, Singleton AB, Parkinson's Disease Biomarkers Program and Parkinson's Progression Marker Initiative investigators.

Lancet Neurol · 2015-08-10

DOI: 10.1016/s1474-4422(15)00178-7PMID: 26271532

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Clinical Determinants of Progression of Parkinson Disease: Predicting Prognosis by Subtype.

Schiess MC, Suescun J.

JAMA Neurol · 2015-08-01

DOI: 10.1001/jamaneurol.2015.1067PMID: 26075915

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.

Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB.

JAMA Neurol · 2015-08-01

DOI: 10.1001/jamaneurol.2015.0703PMID: 26076039

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

1.057 articles found

Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.

Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage.

Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?

Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.

Editorial: Parkinson's disease: cell vulnerability and disease progression.

CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease.

Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine.

Greater motor progression in patients with Parkinson disease who carry LRRK2 risk variants.

Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI).

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.

Clinical Determinants of Progression of Parkinson Disease: Predicting Prognosis by Subtype.

New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.

Filters